|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Accounts receivable | ||||||||||||||||||||
| Income taxes receivable | ||||||||||||||||||||
| Other current assets | ||||||||||||||||||||
| Accounts receivable from related parties | ||||||||||||||||||||
| Stock subscriptions receivable | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Due from related parties | ||||||||||||||||||||
| Investments in unconsolidated entities | ||||||||||||||||||||
| Total other assets | ||||||||||||||||||||
| Non-current assets | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Website development costs | ||||||||||||||||||||
| Capitalized software under development | ||||||||||||||||||||
| Fixed asset | ||||||||||||||||||||
| Operating lease right-of-use asset | ||||||||||||||||||||
| Total property and equipment | ||||||||||||||||||||
| TOTAL ASSETS | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Obligations under finance lease - current portion | ||||||||||||||||||||
| Operating lease right-of-use liability - current portion | ||||||||||||||||||||
| Accounts payable and accrued expenses | ||||||||||||||||||||
| Income taxes payable | ||||||||||||||||||||
| Share application money pending allotment | ||||||||||||||||||||
| Claims incurred but not reported | ||||||||||||||||||||
| Shares pending issuance | ||||||||||||||||||||
| Customer advances from related parties | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Operating lease right-of-use liability - net of current portion | ||||||||||||||||||||
| Guarantee liability | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| EQUITY | ||||||||||||||||||||
| Common stock - par value $.01; 25,000,000 shares authorized; 28,521,620 and 28,521,620 shares issued and outstanding a June 30, 2026 and December 31, 2025. | ||||||||||||||||||||
| Stock based compensation | ||||||||||||||||||||
| Stock to be issued | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Total stockholders' equity | ||||||||||||||||||||
| Noncontrolling interests | ||||||||||||||||||||
| TOTAL LIABILITIES AND EQUITY | ||||||||||||||||||||
Loading...
